Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Refractory B-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT02568553
What this trial is testing

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+23 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT01419795
What this trial is testing

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Fred Hutchinson Cancer Center 3
Early research (Phase 1)UnknownNCT04056975
What this trial is testing

Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Lymphoma
EVIVE Biotechnology 54
Early research (Phase 1)Study completedNCT00217412
What this trial is testing

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

Who this might be right for
Childhood Acute Promyelocytic Leukemia (M3)Childhood Atypical Teratoid/Rhabdoid TumorChildhood Burkitt Lymphoma+16 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00058019
What this trial is testing

Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+3 more
National Cancer Institute (NCI) 51
Early research (Phase 1)Ended earlyNCT04156828
What this trial is testing

Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma

Who this might be right for
Grade 3b Follicular LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+2 more
University of Washington 12
Early research (Phase 1)Study completedNCT03985189
What this trial is testing

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
Kyowa Kirin Co., Ltd. 14
Testing effectiveness (Phase 2)Looking for participantsNCT07283679
What this trial is testing

Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06378190
What this trial is testing

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Who this might be right for
Refractory B-Cell LymphomaB-cell Lymphoma Recurrent
Instituto de Investigación Biomédica de Salamanca 27
Testing effectiveness (Phase 2)Study completedNCT00278161
What this trial is testing

Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 94
Not applicableNot Yet RecruitingNCT07669194
What this trial is testing

Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Ended earlyNCT05453396
What this trial is testing

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+5 more
University of Washington 11
Testing effectiveness (Phase 2)Study completedNCT04074746
What this trial is testing

Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Classic Hodgkin Lymphoma+7 more
M.D. Anderson Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT07123454
What this trial is testing

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma
AstraZeneca 91
Testing effectiveness (Phase 2)Study completedNCT00006225
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+2 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00006020
What this trial is testing

S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 35
Testing effectiveness (Phase 2)Study completedNCT00104858
What this trial is testing

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more
Fred Hutchinson Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT05498220
What this trial is testing

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Ended earlyNCT01483690
What this trial is testing

A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

Who this might be right for
Acute Lymphoblastic LeukemiaPrecursor B-Cell Lymphoblastic LeukemiaPrecursor T-Cell Lymphoblastic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 23
Next Page